Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorption.
about
Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo AcidsIdentification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1.Single- and Multiple-Dose Pharmacokinetics of Once-Daily Formulations of Raltegravir.
P2860
Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorption.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Discovery of MK-8970: an aceta ...... h enhanced colonic absorption.
@en
type
label
Discovery of MK-8970: an aceta ...... h enhanced colonic absorption.
@en
prefLabel
Discovery of MK-8970: an aceta ...... h enhanced colonic absorption.
@en
P2093
P2860
P356
P1433
P1476
Discovery of MK-8970: an aceta ...... h enhanced colonic absorption.
@en
P2093
Abbas M Walji
Allen Templeton
Amrithraj Bennet
Becky Nissley
Christina N Di Marco
Christopher John
David Jonathan Bennett
Gene Chessen
Jaume Balsells
Jay Grobler
P2860
P304
P356
10.1002/CMDC.201402393
P577
2014-12-02T00:00:00Z